Novartis and Roche win appeal against collective abuse fines
A French appellate court has quashed €444 million in fines levied by the country’s antitrust watchdog against Novartis and Roche, ruling that the drugmakers did not abuse their collective dominance by discouraging off-label prescriptions for a cheaper medicine.
To read more
Subscribe to Global Competition Review
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the Global Competition Review experts.